Stock PPLPHARMA PIRAMAL PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 12:43:55 28/06/2024 BST 		5-day change 1st Jan Change
157.2 INR -0.15% Intraday chart for Piramal Pharma Limited +0.41% +13.24%
05-14 Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy MT
05-13 Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024

Valuation

Fiscal Period: March 2023 2024 2025 2026
Capitalization 1 81,683 208,461 - -
Enterprise Value (EV) 1 129,493 209,848 245,264 239,452
P/E ratio -43.6 x 921 x 92.2 x 40.3 x
Yield - 0.13% 0.19% 0.38%
Capitalization / Revenue 1.15 x 2.09 x 2.27 x 2 x
EV / Revenue 1.83 x 2.57 x 2.67 x 2.3 x
EV / EBITDA 20.6 x 17.5 x 17.5 x 13.4 x
EV / FCF -28.1 x 90.4 x 54.3 x 32.6 x
FCF Yield -3.56% 1.11% 1.84% 3.07%
Price to Book 1.21 x 2.63 x 2.43 x 2.28 x
Nbr of stocks (in thousands) 1,193,319 1,325,748 - -
Reference price 2 68.45 157.2 157.2 157.2
Announcement Date 24/05/23 10/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2022 2023 2024 2025 2026
Net sales 1 - 70,816 81,712 91,753 104,289
EBITDA 1 - 6,282 11,963 14,008 17,853
EBIT 1 - -484.5 4,557 5,941 9,658
Operating Margin - -0.68% 5.58% 6.47% 9.26%
Earnings before Tax (EBT) 1 - -1,202 1,793 3,334 7,720
Net income 1 3,760 -1,865 178.2 2,233 5,178
Net margin - -2.63% 0.22% 2.43% 4.97%
EPS 2 3.190 -1.570 0.1400 1.705 3.905
Free Cash Flow 1 - -4,612 2,678 4,513 7,355
FCF margin - -6.51% 3.3% 4.92% 7.05%
FCF Conversion (EBITDA) - - 23.98% 32.22% 41.2%
FCF Conversion (Net income) - - 227.38% 202.1% 142.04%
Dividend per Share 2 - - 0.2000 0.3000 0.6000
Announcement Date 24/05/22 24/05/23 10/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 17,160 21,636 17,488 19,257 20,066 24,784
EBITDA 1 - 873.3 3,513 1,323 2,232 3,011 4,498
EBIT 1 - -771 1,669 -412.9 498 1,307 3,099
Operating Margin - -4.49% 7.71% -2.36% 2.59% 6.51% 12.5%
Earnings before Tax (EBT) 1 - -736.4 948.9 -1,071 348 1,067 2,761
Net income 1 -373.4 -901.8 501.1 -985.8 24.5 832.3 1,970
Net margin - -5.26% 2.32% -5.64% 0.13% 4.15% 7.95%
EPS -0.3100 - - - - - -
Dividend per Share - - - - - - -
Announcement Date 09/11/22 08/02/23 24/05/23 03/08/23 - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023 2024 2025 2026
Net Debt 1 - 47,810 39,320 36,803 30,991
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - 7.61 x 3.287 x 2.627 x 1.736 x
Free Cash Flow 1 - -4,612 2,678 4,513 7,355
ROE (net income / shareholders' equity) - -2.76% 1.76% 3.65% 6.53%
ROA (Net income/ Total Assets) - -1.69% - - -
Assets 1 - 110,312 - - -
Book Value Per Share 2 - 56.80 59.90 64.60 68.90
Cash Flow per Share - - - - -
Capex 1 - 9,648 7,600 7,227 7,259
Capex / Sales - 13.62% 9.37% 7.88% 6.96%
Announcement Date 24/05/22 24/05/23 10/05/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Piramal Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
157.2 INR
Average target price
178 INR
Spread / Average Target
+13.20%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PIRAMAL PHARMA LIMITED Stock Piramal Pharma Limited
+13.24% 2.5B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.05% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
NOVARTIS AG Stock Novartis AG
+13.31% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PPLPHARMA Stock
  4. Financials Piramal Pharma Limited